Myriocin as an atherosclerosis inhibitor

ISSN： 1746-0875

Source： Future Lipidology, Vol.3, Iss.3, 2008-06, pp. : 221-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serine protease inhibitor A3 in atherosclerosis and aneurysm disease

International Journal of Molecular Medicine, Vol. 30, Iss. 2, 2012-01 ,pp. : 288-294

Spandidos Publications

Access to resources Recommend Favorite

The Use of Simvastatin, an HMG CoA Reductase Inhibitor, in Older Patients with Hypercholesterolemia and Atherosclerosis

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 38, Iss. 1, 1990-01 ,pp. : 10-14

John Wiley & Sons Inc

Access to resources Recommend Favorite

Statin Therapy Alone and in Combination with an Acyl-CoA:Cholesterol O-Acyltransferase Inhibitor on Experimental Atherosclerosis

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 1, 2008-03 ,pp. : 9-17

Karger

Access to resources Recommend Favorite

PPARγ and atherosclerosis

By Staels B.

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 13-20

Informa Healthcare

Access to resources Recommend Favorite

Chemokines and atherosclerosis

By Sheikine Yuri Hansson Göran

Annals of Medicine, Vol. 36, Iss. 2, 2004-04 ,pp. : 98-118

Informa Healthcare

Access to resources Recommend Favorite